BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22613725)

  • 1. Dissecting mannose 6-phosphate-insulin-like growth factor 2 receptor complexes that control activation and uptake of plasminogen in cells.
    Leksa V; Pfisterer K; Ondrovičová G; Binder B; Lakatošová S; Donner C; Schiller HB; Zwirzitz A; Mrvová K; Pevala V; Kutejová E; Stockinger H
    J Biol Chem; 2012 Jun; 287(27):22450-62. PubMed ID: 22613725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.
    Schiller HB; Szekeres A; Binder BR; Stockinger H; Leksa V
    Mol Biol Cell; 2009 Feb; 20(3):745-56. PubMed ID: 19037107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble M6P/IGF2R released by TACE controls angiogenesis via blocking plasminogen activation.
    Leksa V; Loewe R; Binder B; Schiller HB; Eckerstorfer P; Forster F; Soler-Cardona A; Ondrovicová G; Kutejová E; Steinhuber E; Breuss J; Drach J; Petzelbauer P; Binder BR; Stockinger H
    Circ Res; 2011 Mar; 108(6):676-85. PubMed ID: 21273553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotin-Chasing Assay to Evaluate uPAR Stability and Cleavage on the Surface of Cells.
    Leksa V; Schiller HB; Stockinger H
    Methods Mol Biol; 2018; 1731():39-47. PubMed ID: 29318541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N terminus of mannose 6-phosphate/insulin-like growth factor 2 receptor in regulation of fibrinolysis and cell migration.
    Leksa V; Godár S; Cebecauer M; Hilgert I; Breuss J; Weidle UH; Horejsí V; Binder BR; Stockinger H
    J Biol Chem; 2002 Oct; 277(43):40575-82. PubMed ID: 12189157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1.
    Godár S; Horejsi V; Weidle UH; Binder BR; Hansmann C; Stockinger H
    Eur J Immunol; 1999 Mar; 29(3):1004-13. PubMed ID: 10092105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells.
    Chang MH; Kuo WW; Chen RJ; Lu MC; Tsai FJ; Kuo WH; Chen LY; Wu WJ; Huang CY; Chu CH
    J Mol Endocrinol; 2008 Aug; 41(2):65-74. PubMed ID: 18495691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of urokinase-type plasminogen activator receptor (uPAR) to the mannose 6-phosphate/insulin-like growth factor II receptor: contrasting interactions of full-length and soluble forms of uPAR.
    Kreiling JL; Byrd JC; Deisz RJ; Mizukami IF; Todd RF; MacDonald RG
    J Biol Chem; 2003 Jun; 278(23):20628-37. PubMed ID: 12665524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.
    Kreiling JL; Montgomery MA; Wheeler JR; Kopanic JL; Connelly CM; Zavorka ME; Allison JL; Macdonald RG
    FEBS J; 2012 Aug; 279(15):2695-713. PubMed ID: 22681933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mannose 6-phosphate/insulin-like growth factor 2 receptor mediates plasminogen-induced efferocytosis.
    Ohradanova-Repic A; Machacek C; Donner C; Mühlgrabner V; Petrovčíková E; Zahradníková A; Vičíková K; Hořejší V; Stockinger H; Leksa V
    J Leukoc Biol; 2019 Mar; 105(3):519-530. PubMed ID: 30657605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
    Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
    Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M6P/IGF2R modulates the invasiveness of liver cells via its capacity to bind mannose 6-phosphate residues.
    Puxbaum V; Nimmerfall E; Bäuerl C; Taub N; Blaas PM; Wieser J; Mikula M; Mikulits W; Ng KM; Yeoh GC; Mach L
    J Hepatol; 2012 Aug; 57(2):337-43. PubMed ID: 22521359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of insulin-like growth factor II (IGF-II)-dependent cell growth by multidentate pentamannosyl 6-phosphate-based ligands targeting the mannose 6-phosphate/IGF-II receptor.
    Zavorka ME; Connelly CM; Grosely R; MacDonald RG
    Oncotarget; 2016 Sep; 7(38):62386-62410. PubMed ID: 27694692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mannose 6-phosphate-binding sites of M6P/IGF2R determine its capacity to suppress matrix invasion by squamous cell carcinoma cells.
    Probst OC; Karayel E; Schida N; Nimmerfall E; Hehenberger E; Puxbaum V; Mach L
    Biochem J; 2013 Apr; 451(1):91-9. PubMed ID: 23347038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids.
    Kang JX; Bell J; Beard RL; Chandraratna RA
    Cell Growth Differ; 1999 Aug; 10(8):591-600. PubMed ID: 10470859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta-induced apoptosis in endothelial cells mediated by M6P/IGFII-R and mini-plasminogen.
    Leksa V; Godar S; Schiller HB; Fuertbauer E; Muhammad A; Slezakova K; Horejsi V; Steinlein P; Weidle UH; Binder BR; Stockinger H
    J Cell Sci; 2005 Oct; 118(Pt 19):4577-86. PubMed ID: 16179614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells.
    Chen Z; Ge Y; Landman N; Kang JX
    BMC Cancer; 2002 Jul; 2():18. PubMed ID: 12149131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of the M6P/IGF-II receptor increases cell proliferation and reduces apoptosis in neonatal rat cardiac myocytes.
    Chen Z; Ge Y; Kang JX
    BMC Cell Biol; 2004 Apr; 5():15. PubMed ID: 15115542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene.
    Oates AJ; Schumaker LM; Jenkins SB; Pearce AA; DaCosta SA; Arun B; Ellis MJ
    Breast Cancer Res Treat; 1998 Feb; 47(3):269-81. PubMed ID: 9516081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.